Held on August 3, 2025, the event was co-hosted by Sofwave, a global leader in medical device technology, and its Vietnamese partner, Vietcan. It brought together aesthetic medicine specialists and hospital representatives from the Asia-Pacific region to share insights on emerging technologies and clinical practices. Dr. Yoon, the sole representative from South Korea, delivered a keynote speech and a live treatment demonstration, both of which received strong acclaim, according to a BrandNew Clinic statement issued on August 13.
TTE Protocol Makes Asian Debut
In her lecture, titled “TTE Energy Delivery: Lift with Precision, Treat with Purpose,” Dr. Yoon outlined the TTE protocol, which harnesses Sofwave’s proprietary Synchronous Ultrasound Parallel Beam (SUPERB) technology. Unlike the conventional Total Treatment Pulses (TTP) method, the TTE protocol represents a move toward precision medicine. It tailors energy delivery by analyzing factors such as skin thickness, elasticity, and subcutaneous fat distribution. Her presentation detailed patient selection criteria, facial analysis, and region-specific treatment strategies, earning widespread praise from attending clinicians.

Advancing Non-Invasive Aesthetic Medicine
“TTE is more than a technical improvement; it redefines non-invasive aesthetic procedures,” Dr. Yoon stated during her address. “It represents an initial step toward individualized aesthetic care, grounded in precision medicine principles.” The protocol is positioned to establish a new benchmark for non-invasive lifting procedures across Asia, with the event serving as a platform for its global dissemination through clinician training.
The Sofwave Elite Meeting 2025 highlighted South Korea’s growing influence in aesthetic medicine, with Dr. Yoon’s TTE protocol receiving recognition as a potential model for future standards. A BrandNew Clinic spokesperson stated, “Dr. Yoon’s TTE protocol significantly improves treatment consistency and ensures more predictable outcomes. We expect it will serve as an important benchmark in global aesthetic practice.”

A Trailblazer in Aesthetic Innovation
Dr. Yoon is recognized as a leading figure in South Korea’s aesthetic medicine community, credited with developing the Contour Injection and YeonA Injection. As a Sofwave Global Key Opinion Leader (KOL) and designated Iconic Provider, she actively contributes to clinical education both in Korea and abroad. She has also served as academic director for the Korean Society of Aesthetic and Plastic Laser Medicine and the Korean Society of Obesity and Aesthetic Treatment, underscoring her role as a prominent contributor to the field.
The introduction of the TTE protocol at the Sofwave Elite Meeting highlights South Korea’s growing leadership in non-invasive aesthetic technologies. Dr. Yoon’s work is expected to help shape the future of precision-based treatments in the Asia-Pacific region and beyond.
Kim Kuk Ju, HEALTH IN NEWS TEAM
press@hinews.co.kr